PALB2 & CHEK2 genes

Please find an overview and risks of the PALB2 and CHEK2 genes.

PALB2

  • Breast Cancer lifetime risk: 30-80% (varies on family history)
  • Ovarian Cancer lifetime risk: 5%
  • Contralateral Breast Cancer lifetime risk: varies on family history

CHEK2 (1100delC variant only)

  • Breast Cancer lifetime risk: 37%
  • Ovarian Cancer lifetime risk: Not significantly increased
  • Possible increased risks for thyroid and Prostate Cancer Currently outside test directory and may be removed.

Order a test

Please call / email:

+44 (0) 207 293 0317

+44 (0) 7722 275780